Research Grade Ublituximab ( 乌妥昔单抗 )
- 发布日期： 2020-10-28
- 更新日期： 2025-10-24
产品详请
| 产地 |
中国
|
| 品牌 |
Chemstan
|
| 货号 |
CSD00255
|
| 保存条件 |
store at -80℃
|
| 用途 |
仅用于科研用途
|
| 应用范围 |
|
| 抗原来源 |
CHO cells
|
| CAS编号 |
1174014-05-1
|
| 保质期 |
一年
|
| 抗体名 |
Ublituximab ( 乌妥昔单抗 )
|
| 是否单克隆 |
|
| 克隆性 |
|
| 靶点 |
MS4A1/CD20[Homo sapiens]
|
| 适应物种 |
|
| 形态 |
|
| 宿主 |
|
| 标记物 |
|
| 包装规格 |
1mg/ml
|
| 纯度 |
%
|
| 亚型 |
|
| 标识物 |
|
| 浓度 |
95%
|
| 免疫原 |
|
| 是否进口 |
否
|
Ublituximab has been used in trials studying the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma, among others.
货号（Catalog No.）
CSD00255
通用名INN
Ublituximab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Ublituximab has been used in trials studying the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma, among others.
别名(Alternative names)
LFB-R603, TG-1101,TGTX-1101
靶点;物种(Specificity target name;species)
MS4A1/CD20[Homo sapiens]
种类(Species)
Chimeric
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
1174014-05-1
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
